Luye Pharma Group Ltd (LUP) — Cash Flow Quality Index
Luye Pharma Group Ltd (LUP) has a Cash Flow Quality Index of 4.60x as of June 2023. Operating cash flow of €344.86 Million exceeds net income of €74.99 Million, indicating high earnings quality where cash backs reported profits. Also explore Luye Pharma Group Ltd (LUP) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luye Pharma Group Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Luye Pharma Group Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LUP goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Luye Pharma Group Ltd (2016–2025)
Year-by-year earnings quality comparison for Luye Pharma Group Ltd. For live market cap and the full company financial profile, see Luye Pharma Group Ltd (LUP) total market value.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | €1.78 Billion | €618.75 Million | ▲ +710.6% |
| 2024 | 0.36x | €167.76 Million | €471.89 Million | ▼ -88.1% |
| 2023 | 3.00x | €1.60 Billion | €532.61 Million | ▲ +9.6% |
| 2022 | 2.73x | €1.65 Billion | €604.81 Million | ▲ +87.0% |
| 2020 | 1.46x | €1.03 Billion | €706.59 Million | ▲ +51.0% |
| 2019 | 0.97x | €1.42 Billion | €1.47 Billion | ▲ +20.8% |
| 2018 | 0.80x | €1.05 Billion | €1.30 Billion | ▼ -18.3% |
| 2017 | 0.98x | €964.10 Million | €981.37 Million | ▲ +47.9% |
| 2016 | 0.66x | €592.03 Million | €891.54 Million | — |